Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash and cash equivalents (Nil at June 30, 2019; including $6,394 of restricted cash at December 31, 2018)	$ 129,021	$ 261,930
Prepaid expenses	14,988	13,931
TOTAL CURRENT ASSETS	144,009	275,861
NON-CURRENT ASSETS
Plant and equipment, net	2,729	3,468
Biological assets	35,510	28,697
TOTAL ASSETS	182,248	308,026
CURRENT LIABILITIES
Accrued liabilities	6,718	27,790
Due to director	78,424	66,355
TOTAL CURRENT LIABILITIES	85,142	94,145
TOTAL LIABILITIES	85,142	94,145
STOCKHOLDERS' EQUITY
Preferred stock - Par value $0.0001; Authorized: 200,000,000 None issued and outstanding
Common stock - Par value $ 0.0001; Authorized: 600,000,000 Issued and outstanding: 141,965,520 shares as of June 30, 2019 and December 31, 2018	14,197	14,197
Additional paid-in capital	650,712	650,712
Accumulated other comprehensive loss	(489)	(460)
Accumulated deficit	(567,314)	(450,568)
TOTAL STOCKHOLDERS' EQUITY	97,106	213,881
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 182,248	$ 308,026